RANBAXY LABORATORIES

ranbaxy-laboratories-logo

Ranbaxy Laboratories Limited, a pharmaceutical company, produces a range of generic medicines. The company has a presence in 49 countries, manufacturing facilities in 11 countries and serves customers in approximately 125 countries. Products The company manufactures and markets generic pharmaceuticals, value added generic pharmaceuticals, branded generics, active Pharmaceuticals (API) and intermediates. Its product basket of approximately 5,000 SKUs available in approximately 125 countries world... wide, encompasses a therapeutic mix covering a majority of the chronic and acute segments. Research & Development The company offers value added formulations based on its Novel Drug Delivery System (NDDS) and New Chemical Entity (NCE) research outcomes. Novel Drug Delivery Systems (NDDS): The company's NDDS focus is mainly on the development of New Drug Applications (NDA) / Abbreviated New Drug Applications (ANDAs) of oral controlled- release products for the regulated markets. Ranbaxy's in-house NDDS programs are primarily focused on the oral segment. Inhalation (patented devices) and trans-dermal (patented adhesive polymers) programs are also being pursued through collaborations. In the oral NDDS space, Ranbaxy has developed four platform technologies namely Gastro Retentive, Modified Matrix, Multiparticulate and AeroGel. New Drug Discovery Research (NDDR): The company's NDDR program focuses on select therapeutic segments of Infectious diseases, Metabolic diseases, Inflammatory/ Respiratory disease and Oncology. The company has 8-10 programs in the area of NDDR. For Arterolane (potential Anti-malarial candidate), the company has obtained approval from the Drug Controller General of India to initiate Phase III human clinical trials in India. The company is also profiling DPP-IV Inhibitors (Di-Peptidyl Peptidase IV Inhibitors) for Type-2-diabetes, a selective Phosphodiesterase 4-b inhibitor for COPD and Asthma, and a novel antibiotic antibacterial for Community Acquired Respiratory Tract Infection. Under an alliance with an academic institution in India, various medicinal plants are being evaluated as potential sources for novel pharmaceutical agents. The company also has collaborative research projects with other academic institutions in India in the area of Respiratory and Infectious disease. Significant Events In June 2008, Ranbaxy entered into an alliance with Daiichi Sankyo Company Ltd., to create a generic pharmaceutical powerhouse. On September 17, 2009, Ranbaxy Laboratories Ltd. has entered into a strategic in-licensing agreement for the Indian market with Medy-Tox Inc. for its cosmetic product, Neuronox. Neuronox is a botulinum toxin type A complex (100 Units) pharmaceutical manufactured by Medy-Tox. History Ranbaxy Laboratories Limited was founded in 1961.

#SimilarOrganizations #People #Financial #Website #More

RANBAXY LABORATORIES

Industry:
Health Care Medical

Founded:
2005-01-01

Address:
Gurgaon, Haryana, India

Country:
India

Website Url:
http://www.ranbaxy.com

Total Employee:
10001+

Status:
Closed

Contact:
9048809645

Email Addresses:
[email protected]

Total Funding:
23 M USD

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS ASP.NET 2.0 Sender ID


Similar Organizations

mylan-laboratories-logo

Mylan Laboratories

Mylan Laboratories is a pharmaceutical company that manufactures and markets generic and specialty drugs.

pharmax-pharmaceuticals-logo

Pharmax Pharmaceuticals

Pharmax Pharmaceuticals is a UAE-based pharmaceutical company which manufactures and markets affordable, branded generic medication.


Current Advisors List

anthony-wild_image

Anthony Wild Board member @ Ranbaxy Laboratories
Board_member

Current Employees Featured

arun-sawhney_image

Arun Sawhney
Arun Sawhney CEO & Managing Director @ Ranbaxy Laboratories
CEO & Managing Director

Founder


malvinder-mohan-singh_image

Malvinder Mohan Singh

Investors List

mape-advisory-group_image

MAPE Advisory Group

MAPE Advisory Group investment in Private Equity Round - Ranbaxy Laboratories

Official Site Inspections

http://www.ranbaxy.com

  • Host name: 104.18.18.79
  • IP address: 104.18.18.79
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ranbaxy Laboratories" on Search Engine